BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23622116)

  • 1. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice.
    Nguyen TA; Frank-Cannon T; Martinez TN; Ruhn KA; Marvin M; Casey B; Treviño I; Hong JJ; Goldberg MS; Tansey MG
    J Neuroinflammation; 2013 Apr; 10():50. PubMed ID: 23622116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration.
    Frank-Cannon TC; Tran T; Ruhn KA; Martinez TN; Hong J; Marvin M; Hartley M; Treviño I; O'Brien DE; Casey B; Goldberg MS; Tansey MG
    J Neurosci; 2008 Oct; 28(43):10825-34. PubMed ID: 18945890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.
    Kitada T; Tong Y; Gautier CA; Shen J
    J Neurochem; 2009 Nov; 111(3):696-702. PubMed ID: 19694908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice.
    Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
    PLoS One; 2016; 11(3):e0151569. PubMed ID: 26982707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
    Paterna JC; Leng A; Weber E; Feldon J; Büeler H
    Mol Ther; 2007 Apr; 15(4):698-704. PubMed ID: 17299411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response.
    Lee JK; McCoy MK; Harms AS; Ruhn KA; Gold SJ; Tansey MG
    J Neurosci; 2008 Aug; 28(34):8517-28. PubMed ID: 18716210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.
    Martinat C; Shendelman S; Jonason A; Leete T; Beal MF; Yang L; Floss T; Abeliovich A
    PLoS Biol; 2004 Nov; 2(11):e327. PubMed ID: 15502868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
    Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
    Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.
    Manning-Boğ AB; Caudle WM; Perez XA; Reaney SH; Paletzki R; Isla MZ; Chou VP; McCormack AL; Miller GW; Langston JW; Gerfen CR; Dimonte DA
    Neurobiol Dis; 2007 Aug; 27(2):141-50. PubMed ID: 17560790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.
    L'episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Impagnatiello F; Marchetti B
    Rejuvenation Res; 2011 Aug; 14(4):411-24. PubMed ID: 21793734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.
    Hennis MR; Seamans KW; Marvin MA; Casey BH; Goldberg MS
    PLoS One; 2013; 8(12):e84894. PubMed ID: 24386432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
    Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
    Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
    Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.
    Hoban DB; Connaughton E; Connaughton C; Hogan G; Thornton C; Mulcahy P; Moloney TC; Dowd E
    Brain Behav Immun; 2013 Jan; 27(1):91-100. PubMed ID: 23044176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.